inhibitors
http://www.yso.fi/onto/yso/p24325
Related publications and other outputs
- Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells (2024) Nafie, Mohamed S.; et al.; A1; OA
- GABAergic inhibition shapes behavior and neural dynamics in human visual working memory (2024) Kujala, Jan; et al.; A1; OA
- Self-assembly, virtual screening of a new cobalt complex : Synthesis, empirical, DFT calculations, biological activity investigations and identification of inhibitory activity on the main protease of COVID-19 and SARS-CoV2 by molecular docking strategy of (C6H6NF)2[Co(SCN)2] (2024) Makhlouf, Jawher; et al.; A1; OA
- A novel alpha-amylase inhibitor-based spirooxindole-pyrrolidine-clubbed thiochromene-pyrzaole pharmacophores : Unveiling the [3+2] cycloaddition reaction by molecular electron density theory (2023) Islam, Mohammad Shahidul; et al.; A1
- Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer : Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation (2023) Salama, Eid E.; et al.; A1; OA
- New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights (2023) Barakat, Assem; et al.; A1; OA
- Synthesis and SARs study of novel spiro‐oxindoles as potent antiproliferative agents with CDK‐2 inhibitory activities (2023) Al‐Jassas, Refaah Mousa; et al.; A1
- Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβ (2023) Laajala, Mira; et al.; A1; OA
- Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades (2022) Shawish, Ihab; et al.; A1; OA
- Discovery of varlaxins, new aeruginosin-type inhibitors of human trypsins (2022) Heinilä L. M., P.; et al.; A1; OA